Someone may be thin with little subcutaneous fat but can still have significant visceral fat, while someone with significant subcutaneous fat may not have as much visceral fat
They are simply a very normal consequence of appetite suppression, but this is also the point where muscle loss risk can begin to increase because when calorie intake drops significantly, especially if protein intake and resistance training are not intentionally maintained, the body may begin pulling from both fat stores and lean tissue during weight loss
State-specific availability of program types, medication options, or consultation requirements may vary
For semaglutide, the starting dose is typically 0.25 mg/week, increasing gradually to 2.4 mg/week for weight management
Going lower risks metabolic adaptation, where your body downregulates metabolism to match the reduced intake, creating the plateau that frustrates so many GLP-1 users
J., Jeppesen, P